Peter Collins

RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA.

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA.

Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA.

Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden.

LU Holding AB (LU Holding) is a venture capital subsidiary of University of Lund founded in 1994. The firm is headquartered in Lund, Sweden.

MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides.

Thylabisco AB focuses on developing therapies for prevention and treatment of obesity. The firm operates as a biopharmaceutical research and development company that develops thylakoids, components of green leaves. It identifies mechanisms to suppress hunger signals and promote reward in the brain. Its product slows down digestion of food and promotes release of satiety signals. The company was founded by Eva Charlotte Erlanson Albertsson on February 22, 2007 and is headquartered in Lund, Sweden.

Part of Agilent Technologies, Inc., Dako ApS is a Danish company that designs and manufactures cancer diagnostic systems. The company is based in Glostrup, Denmark.

CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden.

Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation.

CR Group LP (CRG) is a venture capital firm founded in 2003 by Charles Tate. The firm is headquartered in Houston, Texas.

cTrap AB designs product to protect individuals from harmful pollutants. It offers way to ensure a healthy air indoors. The firm cTrap cloth may be installed indoors on floor, walls, and ceiling which captures the emissions at the source. The company was founded by Per Lennart Larsson in 2013 and is headquartered in Lund, Sweden.

Speximo AB provides emulsifying technology for oil-water based products. The firm’s products and applications include eqmulse and eqlipse. The firm specializes in pickering emulsions and encapsulation technologies. The company was founded by Marilyn Rayner, Timgren Anna Marina Veronica, Petr Dejmek and Malin Elisabet Sjoo in 2012 and is headquartered in Lund, Sweden.

Elinovative AB provides viscous fibers for use in bakery products. It offers ready-to-use bread mixes and bread products. The company was founded by Eva Christina Skjöldebrand, Malin Elisabet Sjöö, Lena Åsheim and Elin Marianne Östman in March 2011 and is headquartered in Kavlinge, Sweden.

ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden.

Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden.

Trophea AB provides medical need for a treatment of skin atrophy caused by long-term use of topical glucocorticoids. The company is headquartered in Helsingborg, Sweden.

ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden.

Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.

Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022.

CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden.

Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.